• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Verily Receives $14.7M Grant from Michael J. Fox Foundation to Create Rich Molecular Dataset for Parkinson’s Research

by Fred Pennic 04/30/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Verily, an Alphabet company focused on health data platforms and AI, today announced it has received a significant $14.7M grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). 

– The funding will support the generation of a comprehensive molecular dataset aimed at accelerating research into Parkinson’s disease.

Building on the Personalized Parkinson’s Project

The new initiative will leverage and significantly expand upon data already gathered through the Personalized Parkinson’s Project (PPP). PPP is an existing two-year longitudinal study of 520 individuals with Parkinson’s disease, conducted as a collaboration between Verily and the Radboud University Medical Center in the Netherlands. The PPP has already amassed detailed clinical histories, behavioral and physiological data from Verily Study Watches, imaging data, and matched biospecimens like blood and cerebrospinal fluid from participants.

Generating Unprecedented Molecular Insights

Parkinson’s disease affects as many as 1 million people in the U.S., with nearly 90,000 new cases diagnosed each year. The ultimate goal of creating this rich, publicly available molecular data resource is to accelerate the development of effective interventions. Researchers using the data hope to improve the diagnosis of Parkinson’s, enhance the ability to monitor disease progression accurately, and gain a deeper understanding of disease mechanisms that can be targeted therapeutically.

The $14.7M grant from MJFF will fund the application of cutting-edge laboratory methods to analyze the biospecimen samples collected during the PPP study. The goal is to create one of the most detailed molecular datasets ever assembled for Parkinson’s disease research by generating:

  • Comprehensive immunogenomic data: To investigate the immune system’s role in Parkinson’s disease pathogenesis.
  • Whole genome sequences: For consented participants, enabling the discovery of genetic factors linked to various aspects of the disease.
  • Metabolomic and alpha-Synuclein data: To explore promising biomarkers for assessing and predicting disease activity and stages.

This deep molecular profiling, combined with the existing real-world data from PPP, is expected to yield significant insights into the mechanisms and signatures of Parkinson’s, including related genetics, immunology, and metabolism.

Accelerating Research via Open Access

Crucially, the resulting integrated dataset – combining the new molecular data with the existing PPP clinical, wearable, and imaging data – will be made available as a public resource for the global research community. Researchers will be able to access and analyze this unified data through Verily Workbench, Verily’s highly scalable platform designed for secure data organization, collaboration, and analysis. This open-access approach aligns with previous collaborations between Verily and MJFF aimed at assembling and sharing valuable Parkinson’s datasets.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |